Global EditionASIA 中文双语Français
China Daily / 2021-04 / 08 / Page011

EU sees AstraZeneca clot link, but backs use

China Daily | Updated: 2021-04-08 00:00

A top official at the European Medicines Agency says there is a causal link between the AstraZeneca coronavirus vaccine and rare blood clots, but that the connection is unclear and the benefits of taking the shot outweigh the risks of getting COVID-19.

Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome's Il Messaggero newspaper on Tuesday that the European Union's medicines regulator is preparing to make a more definitive statement on the topic this week.

Asked about Cavaleri's comments, the EMA press office said its evaluation "has not yet reached a conclusion and the review is currently ongoing". It said it planned a news conference as soon as the review is finalized, possibly on late Wednesday.

Report cites rights progress in Tibet

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US